PHLDA1 knockdown inhibits inflammation and oxidative stress by regulating JNK/ERK pathway, and plays a protective role in sepsis-induced acute kidney injury

Main Article Content

Minmin Gong
Wenmei Liang
Qinju Lu
Jing Zhang

Keywords

acute kidney injury, JNK/ERK pathway, PHLDA1, sepsis

Abstract

Background: Acute kidney injury (AKI), a prevalent complication of sepsis, causes substantial burden on patients’ families as well as the society. More reliable markers are urgently required for the prevention and treatment of AKI. Pleckstrin homology-like domain, family A, member 1 (PHLDA1) was implicated in various diseases, but its involvement in sepsis-induced AKI remains to be explored. The JNK/ERK pathway has been revealed as being involved in progression of sepsis. One previous study demonstrated that PHLDA1 could activate the JNK/ERK pathway in hepatic ischemia/reperfusion injury. Nevertheless, involvement of PHLDA1 in sepsis-triggered AKI through the JNK/ERK pathway has not been probed.


Methods: A cecal ligation and punctured (CLP) mice model of sepsis-induced AKI was established. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunofluorescence staining were applied to evaluate the expression of PHLDA1. Concentration of blood urea nitrogen (BUN) and serum creatinine (Scr), inflammation markers, including interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-α, as well as oxidative stress-associated proteins (catalase, malondialdehyde, superoxide dismutase, and glutathione), in the kidney tissues of mice were evaluated by enzyme-linked-immunosorbent serologic assay. Western blot analysis was applied for measuring protein expression levels.


Results: The BUN and SCr levels in mice were obviously elevated in the CLP group compared to the sham group. Moreover, the expression of PHLDA1 was also elevated in the CLP group in comparison to the sham group. Down-regulation of PHLDA1 alleviated renal injury, inflammation, and oxidative stress in AKI model. Mechanistic study showed that PHLDA1 knockdown suppressed the activation of c-JUN N-terminal kinase/p38 and extracellular signal-regulated kinase (JNK/ERK) pathway.


Conclusion: Down-regulation of PHLDA1 suppressed inflammation and oxidative stress through the modulation of JNK/ERK pathway in sepsis-induced AKI. The results could offer a novel insight into the treatment of patients with sepsis-induced AKI.

Abstract 229 | PDF Downloads 225 HTML Downloads 22 XML Downloads 13

References

1. Souza DC, Jaramillo-Bustamante JC, Céspedes-Lesczinsky M, Quintero EMC, Jimenez HJ, Jabornisky R, et al. Challenges and health-care priorities for reducing the burden of paediatric sepsis in Latin America: A call to action. Lancet Child Adolesc Health. 2022;6(2):129–36. 10.1016/S2352-4642(21)00341-2

2. Li S, Sun Y, Tang X, Wang L, Cheng X. miR-20a attenuates acute lung injury in septic rats via targeting TLR4. Signa Vitae. 2021;17(4):157–62.

3. Zhang T, Xiang L. Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway. Cell Mol Biol Lett. 2019;24:15. 10.1186/s11658-019-0142-4

4. Kahraman D, Diniz G, Sayham S, Ersavas S, Ayaz D, Keskin E, et al. Over expressions of neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in human uterine cervical neoplasms enhance tumor invasion. Eur J Gynaecol Oncol. 2021;42(1):148–53. 10.31083/j.ejgo.2021.01.2195

5. Song C, Adili A, Kari A, Abuduhaer A. FSTL1 aggravates-sepsis-induced acute kidney injury through regulating TLR4/MyD88/NF-kappa B pathway in newborn rats. Signa Vitae. 2021;17(3):167–73.

6. Kalantari K, Rosner MH. Recent advances in the pharmacological management of sepsis-associated acute kidney injury. Expert Rev Clin Pharmacol. 2021;14(11):1401–11. 10.1080/17512433.2021.1978287

7. Jia Y, Li Z, Feng Y, Cui R, Dong Y, Zhang X, et al. Methane-rich saline ameliorates sepsis-induced acute kidney injury through anti-inflammation, antioxidative, and antiapoptosis effects by regulating endoplasmic reticulum stress. Oxidat Med Cell Longevity. 2018;2018:4756846. 10.1155/2018/4756846

8. Quaglia M, Merlotti G, Colombatto A, Bruno S, Stasi A, Franzin R, et al. Stem cell-derived extracellular vesicles as potential therapeutic approach for acute kidney injury. Front Immunol. 2022;13:849891. 10.3389/fimmu.2022.84989

9. Tatar B. Assessment of myometrial invasion of endometrial carcinoma with preoperative transvaginal sonography. Eur J Gynaecol Oncol. 2021;42(1):85–9. 10.31083/j.ejgo.2021.01.2236

10. Guo Y, Jia P, Chen Y, Yu H, Xin X, Bao Y, et al. PHLDA1 is a new therapeutic target of oxidative stress and ischemia-reperfusion-induced myocardial injury. Life Sci. 2020;245: 117347. 10.1016/j.lfs.2020.117347

11. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42; quiz e30. 10.1053/j.gastro.2011.10.001

12. Scheffzek K, Welti S. Pleckstrin homology (PH) like domains–Versatile modules in protein–protein interaction platforms. FEBS Lett. 2012;586(17):2662–73. 10.1016/j.febslet.2012.06.006

13. Zhao P, Lu Y, Liu L. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma. Int J Clin Exp Pathol. 2015;8(5):5230–5.

14. Yang F, Chen R. Loss of PHLDA1 has a protective role in OGD/R-injured neurons via regulation of the GSK-3β/Nrf2 pathway. Human Exp Toxicol. 2021;40(11):1909–20. 10.1177/09603271211014596

15. Orita F, Ishikawa T, Ishiguro M, Okazaki S, Kikuchi A, Yamauchi S, et al. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia. Mol Clin Oncol. 2021;15(3):192. 10.3892/mco.2021.2354

16. Xu J, Bi G, Luo Q, Liu Y, Liu T, Li L, et al. PHLDA1 modulates the endoplasmic reticulum stress response and is required for resistance to oxidative stress-induced cell death in human ovarian cancer cells. J Cancer. 2021;12(18):5486–93. 10.7150/jca.45262

17. Luo YH, Huang ZT, Zong KZ, Cao ZR, Peng DD, Zhou BY, et al. miR-194 ameliorates hepatic ischemia/reperfusion injury via targeting PHLDA1 in a TRAF6-dependent manner. Int Immunopharmacol. 2021;96:107604. 10.1016/j.intimp.2021.107604

18. Zhang Z, Zhao H, Ge D, Wang S, Qi B. β-Casomorphin-7 ameliorates sepsis-induced acute kidney injury by targeting NF-κB pathway. Med Sci Monit Int Med J Exp Clin Res. 2019;25:121–7. 10.12659/MSM.912730

19. Li X, Zheng P, Ji T, Tang B, Wang Y, Bai S. LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway. Aging. 2020;13(1):340–50. 10.18632/aging.104152

20. Zhao W, Zhang L, Chen R, Lu H, Sui M, Zhu Y, et al. SIRT3 protects against acute kidney injury via AMPK/mTOR--regulated autophagy. Front Physiol. 2018;9:1526. 10.3389/fphys.2018.01526

21. Zhang N, Zhao W, Hu ZJ, Ge SM, Huo Y, Liu LX, et al. Protective effects and mechanisms of high-dose vitamin C on sepsis--associated cognitive impairment in rats. Sci Rep. 2021;11(1):14511. 10.1038/s41598-021-93861-x

22. Zhang C, Suo M, Liu L, Qi Y, Zhang C, Xie L, et al. Melatonin alleviates contrast-induced acute kidney injury by activation of Sirt3. Oxidat Med Cell Long. 2021;2021:6668887. 10.1155/2021/6668887

23. Plotnikov EY, Pevzner IB, Zorova LD, Chernikov VP, Prusov AN, Kireev II, et al. Mitochondrial damage and mitochondria--targeted antioxidant protection in LPS-induced acute kidney injury. Antioxidants (Basel, Switzerland). 2019;8(6):176. 10.3390/antiox8060176

24. Gao F, Qian M, Liu G, Ao W, Dai D, Yin C. USP10 alleviates sepsis-induced acute kidney injury by regulating Sirt6-mediated Nrf2/ARE signaling pathway. J Inflamm (London). 2021;18(1):25. 10.1186/s12950-021-00291-7

25. Zhang WQ, Wang HJ, Li YZ, Du XF, Hao XL, Jiang HM, et al. Inhibition of microRNA-543 alleviates sepsis-induced acute kidney injury via targeting Bcl-2. Eur Rev Med Pharmacol Sci. 2022;26(7):2305–12.

26. Peng Y, Li Y, Li H, Yu J. Shikonin attenuates kidney tubular epithelial cells apoptosis, oxidative stress, and inflammatory response through nicotinamide adenine dinucleotide phosphate oxidase 4/PTEN pathway in acute kidney injury of sepsis model. Drug Dev Res. 2022. 10.1002/ddr.21936

27. Zhang Y, Song C, Ni W, Pei Q, Wang C, Ying Y, et al. HSP70 ameliorates septic acute kidney injury via binding with TRAF6 to inhibit of inflammation-mediated apoptosis. J Inflamm Res. 2022;15:2213–28. 10.2147/JIR.S352717

28. Wang B, Xu J, Ren Q, Cheng L, Guo F, Liang Y, et al. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis. Cell Death Dis. 2022;13(4):333. 10.1038/s41419-022-04794-w

29. Nadeem A, Siddiqui N, Al-Harbi NO, Attia SM, AlSharari SD, Ahmad SF. Acute lung injury leads to depression-like symptoms through upregulation of neutrophilic and neuronal NADPH oxidase signaling in a murine model. Int Immunopharmacol. 2017;47:218–26. 10.1016/j.intimp.2017.04.010

30. Nadeem A, Al-Harbi NO, Ahmad SF, Ibrahim KE, Siddiqui N, Al-Harbi MM. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species. Clin Exp Immunol. 2018;191(3):279–87. 10.1111/cei.13097

31. Nadeem A, Ahmad SF, Al-Harbi NO, Al-Harbi MM, Ibrahim KE, Kundu S, et al. Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice. Int Immunopharmacol. 2019;68:39–47. 10.1016/j.intimp.2018.12.062

32. Nadeem A, Al-Harbi NO, Ahmad SF, Al-Harbi MM, Alhamed AS, Alfardan AS, et al. Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress. Int Immunopharmacol. 2020;83:106369. 10.1016/j.intimp.2020.106369

33. Nadeem A, Al-Harbi NO, Alfardan AS, Ahmad SF, AlAsmari AF, Al-Harbi MM. IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in mice. Biomed Pharmacother Biomed Pharmacother. 2018;107:1196–204. 10.1016/j.biopha.2018.08.123

34. Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, Alanazi WA, et al. Bruton's tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice. Int Immunopharmacol. 2021;90:107123. 10.1016/j.intimp.2020.107123

35. Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Sarawi W, Attia SM, et al. Role of ITK signaling in acute kidney injury in mice: Amelioration of acute kidney injury associated clinical parameters and attenuation of inflammatory transcription factor signaling in CD4+ T cells by ITK inhibition. Int Immunopharmacol. 2021;99:108028. 10.1016/j.intimp.2021.108028

36. Al-Harbi NO, Nadeem A, Ahmad SF, Alanazi MM, Aldossari AA, Alasmari F. Amelioration of sepsis-induced acute kidney injury through inhibition of inflammatory cytokines and oxidative stress in dendritic cells and neutrophils respectively in mice: Role of spleen tyrosine kinase signaling. Biochimie. 2019;158:102–10. 10.1016/j.biochi.2018.12.014

37. Xu F, Xie Q, Li YW, Jing QQ, Liu XJ, Xu YC, et al. Suppression of JNK/ERK dependent autophagy enhances Jaspine B derivative-induced gastric cancer cell death via attenuation of p62/Keap1/Nrf2 pathways. Toxicol Appl Pharmacol. 2022;438:115908. 10.1016/j.taap.2022.115908

38. Jayakumar T, Hou SM, Chang CC, Fong TH, Hsia CW, Chen YJ, et al. Columbianadin dampens in vitro inflammatory actions and inhibits liver injury via inhibition of NF-κB/MAPKs: Impacts on (∙)OH radicals and HO-1 expression. Antioxidants (Basel, Switzerland). 2021;10(4):553. 10.3390/antiox10040553

39. Jin H, Wang M, Wang J, Cao H, Niu W, Du L. Paeonol attenuates isoflurane anesthesia-induced hippocampal neurotoxicity via modulation of JNK/ERK/P38MAPK pathway and regulates histone acetylation in neonatal rat. J Matern Fetal Neonatal Med. 2020;33(1):81–91. 10.1080/14767058.2018.1487396

40. Fang Q, Wang J, Zhang Y, Wang L, Li W, Han J, et al. Inhibition of myeloid differentiation factor-2 attenuates obesity--induced cardiomyopathy and fibrosis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(1):252–62. 10.1016/j.bbadis.2017.09.026

41. Kim KM, Kim SY, Mony TJ, Bae HJ, Han SD, Lee ES, et al. Dracocephalum moldavica ethanol extract suppresses LPS-induced inflammatory responses through inhibition of the JNK/ERK/NF-κB signaling pathway and IL-6 production in RAW 264.7 macrophages and in endotoxic-treated mice.Nutrients. 2021;13(12):4501. 10.3390/nu13124501

42. Cohen TS, Gray Lawrence G, Margulies SS. Cultured alveolar epithelial cells from septic rats mimic in vivo septic lung. PloS One. 2010;5(6):e11322. 10.1371/journal.pone.0011322

43. Li P, Chen XR, Xu F, Liu C, Li C, Liu H, et al. Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways. Life Sci. 2018;206:106–16. 10.1016/j.lfs.2018.04.010

44. Pizzino G, Bitto A, Pallio G, Irrera N, Galfo F, Interdonato M, et al. Blockade of the JNK signalling as a rational therapeutic approach to modulate the early and late steps of the inflammatory cascade in polymicrobial sepsis. Mediat Inflamm. 2015;2015:591572. 10.1155/2015/591572